{"id":1080,"date":"2026-04-14T10:12:26","date_gmt":"2026-04-14T09:12:26","guid":{"rendered":"https:\/\/jessicafonteneaunutrition.com\/?p=1080"},"modified":"2026-04-14T10:18:02","modified_gmt":"2026-04-14T09:18:02","slug":"negative-allergy-test-but-strong-reactions-this-is-a-thing","status":"publish","type":"post","link":"https:\/\/jessicafonteneaunutrition.com\/fr\/negative-allergy-test-but-strong-reactions-this-is-a-thing\/","title":{"rendered":"Test d'allergie n\u00e9gatif mais r\u00e9actions fortes ? C'est possible."},"content":{"rendered":"\n

This is the fully referenced article delving into the immunology, i<\/a>f you want my Substack article that focuses on the lived experience, please use this link. <\/a><\/em><\/p>\n\n\n\n

There is a particular kind of clinical frustration that arises when a patient presents with a consistent, reproducible physiological response, yet all available testing suggests there is nothing to find. This is not simply a difference in interpretation. It reflects a structural limitation in how immune responses are currently assessed, interpreted, and acted upon in practice.<\/p>\n\n\n\n

This is not only something I observe in clinic. This actually happened to me last week. <\/p>\n\n\n\n

I was referred back to an allergy specialist following a progression in my own symptom pattern. What had previously been a reaction limited to ingestion had evolved, first to contact, and then to airborne exposure. Within minutes of exposure, I experienced swelling of the fingers, inflammation around the nail beds, and tightening of the throat. Crucially, I experienced a clear change in my voice, a clinical sign of laryngeal involvement that typically serves as an immediate “red flag” for airway compromise in any other diagnostic context.<\/p>\n\n\n\n

Despite these rapid and observable symptoms, a negative skin prick test was considered sufficient to conclude that there was no clinically relevant allergy and no further action required. The consultation was more than brief, I spent a total of 25 minutes at the clinic, 10 of which were in the waiting room before I saw anyone. <\/p>\n\n\n\n

There was no exploration of the pattern, the progression, or the route of exposure. On leaving the clinic, as symptoms progressed, I returned to report what was happening and was advised not to be “emotional,” reassured that I was not going to die, and told to avoid the trigger if it “caused discomfort.”<\/p>\n\n\n\n

This experience is not unusual. It reflects a wider issue in the way food-related immune responses are currently conceptualised and managed. I was almost expecting it, my husband certainly was and unfortunately I hear similar stories from my clients day in and day out. <\/p>\n\n\n\n

The limitations of an IgE-centric model<\/h2>\n\n\n\n

The current diagnostic framework for food allergy is heavily weighted towards IgE-mediated mechanisms. Skin prick testing and serum-specific IgE measurements are widely used and, in the context of IgE-mediated allergy, clinically valuable. However, the assumption that a negative IgE result excludes clinically significant immune reactivity is not supported by the broader literature.<\/p>\n\n\n\n

Non-IgE-mediated food hypersensitivity is well described, particularly in gastrointestinal and dermatological conditions [1\u20133]<\/strong>. These reactions do not involve allergen-specific IgE antibodies and therefore are not detected by conventional testing. In practice, this creates a binary model in which positive results are prioritised and negative results often lead to dismissal, even in the presence of a consistent clinical history.<\/p>\n\n\n\n

Evidence suggests that no single diagnostic test reliably identifies non-IgE-mediated food hypersensitivity. Instead, diagnosis relies on a combination of clinical history, elimination and reintroduction, and, where appropriate, oral food challenge [1,2]<\/strong>. This reflects a fundamental limitation in relying on laboratory markers alone.<\/p>\n\n\n\n

Non-IgE immune pathways and mast cell involvement<\/h2>\n\n\n\n

The absence of IgE does not equate to absence of immune activation. A range of non-IgE-mediated mechanisms have been described, including T cell-mediated responses and other forms of immune activation that do not rely on allergen-specific IgE [2,3]<\/strong>.<\/p>\n\n\n\n

Furthermore, emerging research suggests that mast cell activation, the primary driver of many allergic symptoms, can occur independently of IgE. The MRGPRX2 receptor<\/strong>, for instance, allows for the direct activation of mast cells by various substances, bypassing the traditional allergic pathway. Similarly, the concept of \u201centopy\u201d<\/strong>, the localised production of IgE within specific tissues (such as the skin or mucosal surfaces) without a corresponding systemic signal, explains why a patient may react intensely despite negative blood or skin prick tests.<\/p>\n\n\n\n

Whilst non-IgE-mediated reactions are often described as delayed, this does not exclude the possibility of rapid symptom onset. Clinical presentations are heterogeneous, and strict categorisation into \u201cimmediate IgE\u201d and \u201cdelayed non-IgE\u201d fails to capture the complexity of these localised or non-canonical pathways [2]<\/strong>.<\/p>\n\n\n\n

Food hypersensitivity in atopic conditions<\/h2>\n\n\n\n

In individuals with atopic dermatitis, the relationship between food and immune reactivity is particularly complex. Non-IgE-mediated reactions are reported in a significant proportion of cases, with prevalence estimates ranging from 10% to over 50% depending on the population studied and the diagnostic criteria used [6,10]<\/strong>.<\/p>\n\n\n\n

Common triggers include cow\u2019s milk and hen\u2019s egg, although a wide range of foods may be implicated [8,9]<\/strong>. These reactions may present with cutaneous, gastrointestinal, or combined symptom profiles, and are often associated with underlying barrier dysfunction. Impaired skin integrity facilitates antigen exposure and local immune activation, contributing to increased reactivity. In this context, reliance on IgE testing alone risks under-recognition of clinically relevant food responses.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\"\"<\/figure>\n\n\n\n
<\/div>\n\n\n\n

The clinical importance of pattern recognition<\/h2>\n\n\n\n

In the absence of a single reliable diagnostic test, clinical reasoning must remain central. A consistent trigger, a reproducible response, and a predictable timeline constitute meaningful clinical data. These principles underpin diagnosis across medicine, yet in the context of food hypersensitivity, they are often secondary to laboratory findings.<\/p>\n\n\n\n

Oral food challenge remains the gold standard for diagnosis precisely because it captures real-world responses that laboratory tests may miss [1,4]<\/strong>. The interpretation of negative results requires caution: absence of evidence is not evidence of absence, particularly when the test in question assesses only one specific pathway of a multifaceted immune response.<\/p>\n\n\n\n

Route of exposure and evolving reactivity<\/h2>\n\n\n\n

Food reactions are typically considered in the context of ingestion. However, exposure can occur through multiple routes, including skin contact and inhalation. The progression from ingestion to contact to inhalation, as observed in my own case, suggests a lowering of threshold and an expansion of reactivity.<\/p>\n\n\n\n

A robust clinical model should be route-agnostic<\/strong>, recognising that the immune system does not exclusively encounter antigens through the gut. Failure to account for diverse routes of exposure contributes to the under-recognition of symptoms and the misinterpretation of clinical relevance.<\/p>\n\n\n\n

Implications for clinical practice<\/h2>\n\n\n\n

The gap between measurable markers and lived physiology has practical consequences. Patients with clear, reproducible symptoms may be reassured inappropriately, leading to continued exposure and symptom progression. In some cases, they may be labelled as “anxious,” or in my case, “emotional”, shifting the focus away from physiological mechanisms.<\/p>\n\n\n\n

Management must be guided by clinical reality. Where a clear trigger is identified, avoidance is a rational and protective strategy. It is also important to consider factors that influence reactivity, including barrier integrity, stress, and overall inflammatory load. A broader, integrated approach is required, one that acknowledges the limitations of current testing and prioritises clinical observation.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\"Negative<\/figure>\n\n\n\n
<\/div>\n\n\n\n

Conclusion<\/h2>\n\n\n\n

When a patient presents with a clear, reproducible reaction, a negative test should not end the conversation. It should prompt further exploration.<\/p>\n\n\n\n

The current model of allergy, whilst valuable, is incomplete. To ignore a reproducible, multi-system physiological response in favour of a single negative laboratory result is not “evidence-based medicine”, it is a failure of clinical observation. Consistency in symptom presentation is not incidental; it is clinically meaningful. <\/p>\n\n\n\n

Recognising this is essential if we are to provide care that reflects the complexity of immune function rather than the limitations of our current testing methods.<\/p>\n\n\n\n

\n\n\n\n

Clinical Pearls: Navigating the Negative Test<\/h3>\n\n\n\n
Feature<\/th>Clinical Significance<\/th><\/tr><\/thead>
Reproducibility<\/strong><\/td>A consistent response to a specific trigger is primary clinical data, regardless of IgE status.<\/td><\/tr>
Voice\/Airway<\/strong><\/td>Any change in voice or throat tightening is a high-level clinical sign, not a subjective “emotion.”<\/td><\/tr>
Route of Exposure<\/strong><\/td>Reactivity can evolve from ingestion to contact or inhalation; all routes are immunologically valid.<\/td><\/tr>
Testing Limits<\/strong><\/td>Standard tests do not account for MRGPRX2-mediated activation or localised “entopy.”<\/td><\/tr>
Patient Safety<\/strong><\/td>If a trigger causes a systemic or multi-system response, avoidance is the only evidence-based management.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

References<\/h2>\n\n\n\n
    \n
  1. Fogg MI, Brown-Whitehorn TA, Pawlowski NA, Spergel JM. Atopy patch test for the diagnosis of food protein-induced enterocolitis syndrome. Pediatr Allergy Immunol<\/em>. 2006;17(5):351\u20135. View on PubMed<\/a><\/li>\n\n\n\n
  2. Cuomo B, Anania C, D\u2019Auria E, et al. The role of the atopy patch test in the diagnostic work-up of non-IgE gastrointestinal food allergy in children: a systematic review. Eur J Pediatr<\/em>. 2023;182(7):3045\u201358. View on PubMed<\/a><\/li>\n\n\n\n
  3. Nomura I, Morita H, Hosokawa S, et al. Four distinct subtypes of non-IgE-mediated gastrointestinal food allergies in neonates and infants, distinguished by their initial symptoms. J Allergy Clin Immunol<\/em>. 2011;127(3):685\u201393. View on PubMed<\/a><\/li>\n\n\n\n
  4. J\u00e4rvinen KM, Sicherer SH. Diagnostic oral food challenges: procedures and biomarkers. J Immunol Methods<\/em>. 2012;383(1\u20132):30\u20138. View on PubMed<\/a><\/li>\n\n\n\n
  5. Carroccio A, Brusca I, Mansueto P, et al. Fecal assays detect hypersensitivity to cow\u2019s milk protein and gluten in adults with irritable bowel syndrome. Clin Gastroenterol Hepatol<\/em>. 2011;9(7):613\u201320. View on PubMed<\/a><\/li>\n\n\n\n
  6. Niggemann B, Reibel S, Roehr CC, et al. Predictors of positive food challenge outcome in non-IgE-mediated reactions to food in children with atopic dermatitis. J Allergy Clin Immunol<\/em>. 2001;108(6):1053\u20138. View on PubMed<\/a><\/li>\n\n\n\n
  7. Kalach N, Kapel N, Waligora-Dupriet AJ, et al. Intestinal permeability and fecal eosinophil-derived neurotoxin are the best diagnostic tools for digestive non-IgE-mediated cow\u2019s milk allergy in toddlers. Clin Chem Lab Med<\/em>. 2012;50(2):351\u20138. View on PubMed<\/a><\/li>\n\n\n\n
  8. Isolauri E, Turjanmaa K. Combined skin prick and patch testing enhances identification of food allergy in infants with atopic dermatitis. J Allergy Clin Immunol<\/em>. 1996;97(1 Pt 1):9\u201315. View on PubMed<\/a><\/li>\n\n\n\n
  9. Francavilla R, Lor\u00e8 M, Leone M, et al. The diagnostic value of atopy patch test and skin prick test in late-phase clinical reactions to food in children with atopic dermatitis. J Pediatr Gastroenterol Nutr<\/em>. 2006;43(3):372\u20139. View on PubMed<\/a><\/li>\n\n\n\n
  10. Cogurlu MT, Aydogan M, Cavkaytar O, et al. Phenotypes of food allergies in patients with atopic dermatitis aged under 24 months: a multicenter study. Diagnostics (Basel)<\/em>. 2025;15(20):2656. View on MDPI<\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    Lorsqu'un patient pr\u00e9sente une r\u00e9action claire et reproductible, un test n\u00e9gatif ne devrait pas mettre un terme \u00e0 la discussion. Il devrait inciter \u00e0 une exploration plus approfondie.<\/p>","protected":false},"author":4,"featured_media":1082,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[10,17,14],"tags":[],"class_list":["post-1080","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-allergies-intolerances","category-eczema","category-histamine"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t